10Sep 2017

REFRACTORY THROMOBOTIC ANTI-PHOSPHOLIPID SYNDROME MANIFESTING WITH BUDD CHIARI SYNDROME AND PULMONARY EMBOLISM.

  • Department of Medicine, King Fahad Specialist Hospital-Dammam, Saudi Arabia.
Crossref Cited-by Linking logo
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author
  1. Chighizola C, Ubiali T, Meroni P. Treatment of Thrombotic Antiphospholipid Syndrome: The Rationale of Current Management?An Insight into Future Approaches.?Journal of Immunology Research. 2015;2015:1-20. doi:10.1155/2015/951424.
  2. MIYAKIS S, LOCKSHIN M, ATSUMI T et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).?Journal of Thrombosis and Haemostasis. 2006;4(2):295-306. doi:10.1111/j.1538-7836.2006.01753.x.
  3. Roubey R. Risky business: the interpretation, use, and abuse of antiphospholipid antibody tests in clinical practice.?Lupus. 2010;19(4):440-445. doi:10.1177/0961203310361356.
  4. Scoble T, Wijetilleka S, Khamashta M. Management of refractory anti-phospholipid syndrome.?Autoimmunity Reviews. 2011;10(11):669-673. doi:10.1016/j.autrev.2011.04.030.
  5. Espinosa G, Cervera R. Current treatment of antiphospholipid syndrome: lights and shadows.?Nature Reviews Rheumatology. 2015;11(10):586-596. doi:10.1038/nrrheum.2015.88.
  6. Crowther M, Ginsberg J, Julian J. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome.?ACC Current Journal Review. 2004;13(1):15. doi:10.1016/j.accreview.2003.10.079.

[Sherif A. Nasef, , Amer S. Zahralliyali, Mazen A. Elyahia, Ahmed Y. Alothman and Hanan M.Alrammah (2017); REFRACTORY THROMOBOTIC ANTI-PHOSPHOLIPID SYNDROME MANIFESTING WITH BUDD CHIARI SYNDROME AND PULMONARY EMBOLISM. Int. J. of Adv. Res. 5 (Sep). 403-405] (ISSN 2320-5407). www.journalijar.com


Amer S. Zahralliyali


DOI:


Article DOI: 10.21474/IJAR01/5343      
DOI URL: http://dx.doi.org/10.21474/IJAR01/5343